# A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers

> **NCT00002261** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Smallpox Vaccine
- **BIOLOGICAL:** HIVAC-1e
- **BIOLOGICAL:** gp160 Vaccine (MicroGeneSys)

## Key facts

- **NCT ID:** NCT00002261
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002261, "A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00002261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*